https://www.pharmefex.com/news/pharmefex-brief-on-fda-precheck-and-amt 2025-09-30 https://www.pharmefex.com/news/what-the-hhs-layoffs-mean-for-biotech-and-what-companies-should-do-now 2025-07-16 https://www.pharmefex.com/news/why-including-pregnant-women-in-clinical-trials-is-essential-for-ethical-and-effective-drug-development 2025-06-12 https://www.pharmefex.com/news/why-biotech-developers-must-act-now-on-nitrosamine-risk-management 2025-06-05 https://www.pharmefex.com/news/why-outsourced-project-management-and-regulatory-compliance-are-the-future-of-biotech 2025-06-04 https://www.pharmefex.com/news/the-rise-of-adcs-why-outsourcing-and-supply-chain-diversification-are-critical-to-success 2025-05-21 https://www.pharmefex.com/news/navigating-the-complexities-of-cmc-strategy-in-cell-and-gene-therapy-development 2025-05-13 https://www.pharmefex.com/news/fda-endorses-shift-toward-non-animal-testing-a-transformative-step-in-drug-development 2025-04-30 https://www.pharmefex.com/news/ich-publishes-revised-q1a-r3-stability-guidline-strategic-considerations 2025-04-30 https://www.pharmefex.com/news/dr.-grace-lee-joins-pharmefex 2025-04-22 https://www.pharmefex.com/news/klaus-beck%2C-md%2C-ph.d.-joins-pharmefex 2025-04-22 https://www.pharmefex.com/news/kuldip-sra%2C-ph.d.-joins-pharmefex 2025-04-22 https://www.pharmefex.com/news/pharmefex-and-dahlia-consulting-announce-the-creation-of-a-strategic-partnership 2025-04-22 https://www.pharmefex.com/news/pharmefex-and-beck-life-sciences-announce-creation-of-strategic-collaboration 2025-04-22 https://www.pharmefex.com/news/pharmefex-and-jeff-yuen-and-associates-announce-creation-of-partnership 2025-04-22 https://www.pharmefex.com/news/pharmefex-and-cddg-announce-creation-of-strategic-partnership 2025-04-22 https://www.pharmefex.com/news/bio-process-online-article-and-interview-with-dr.-siahpush-on-cell-therapy-tech-transfer 2025-04-22